CDRH Compliance Director Steve Silverman Leaving FDA
This article was originally published in The Gray Sheet
Executive Summary
Silverman, who is moving on to pursue "opportunities outside of government," will be replaced on an interim basis by Jan Welch, deputy director for regulatory affairs in the compliance office.
You may also be interested in...
CDRH Office Of Compliance Shifts To “Function-Based Structure”
FDA’s device center Office of Compliance is reorganizing. Major goals are to organize staff around functions rather than product categories, increase attention to underserved areas and strengthen the office’s international focus.
CDRH To Beef Up Monitoring Of Device Ads And Promotions
CDRH will expand its staff devoted to monitoring device advertising and promotions activity as part of a reorganization of its Office of Compliance.
Probiotics And Cold Remedies Boost Recordati In 2023
Italy's Recordati saw its OTC sales grow by 10% in 2023 driven by the recovery of the cough & cold market and a growing demand for probiotics.